- Home
- TD vs BMY Comparison
TD vs BMY Comparison
Compare TD & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TD
- BMY
- Stock Information
- Founded
- TD 1855
- BMY 1887
- Country
- TD Canada
- BMY United States
- Employees
- TD N/A
- BMY N/A
- Industry
- TD
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- TD
- BMY Health Care
- Exchange
- TD Nasdaq
- BMY Nasdaq
- Market Cap
- TD 105.0B
- BMY 120.5B
- IPO Year
- TD N/A
- BMY N/A
- Fundamental
- Price
- TD $60.29
- BMY $60.02
- Analyst Decision
- TD Buy
- BMY Hold
- Analyst Count
- TD 2
- BMY 14
- Target Price
- TD $83.50
- BMY $58.00
- AVG Volume (30 Days)
- TD 1.8M
- BMY 12.4M
- Earning Date
- TD 05-22-2025
- BMY 04-24-2025
- Dividend Yield
- TD 4.89%
- BMY 4.13%
- EPS Growth
- TD N/A
- BMY N/A
- EPS
- TD 3.26
- BMY N/A
- Revenue
- TD $36,873,924,749.00
- BMY $48,300,000,000.00
- Revenue This Year
- TD $9.02
- BMY N/A
- Revenue Next Year
- TD $4.49
- BMY N/A
- P/E Ratio
- TD $18.51
- BMY N/A
- Revenue Growth
- TD 0.91
- BMY 7.32
- 52 Week Low
- TD $51.25
- BMY $39.35
- 52 Week High
- TD $64.91
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- TD 56.17
- BMY 53.02
- Support Level
- TD $59.09
- BMY $58.53
- Resistance Level
- TD $61.39
- BMY $61.49
- Average True Range (ATR)
- TD 0.82
- BMY 1.39
- MACD
- TD 0.10
- BMY -0.21
- Stochastic Oscillator
- TD 74.48
- BMY 35.10
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, US retail banking, and wholesale banking. The bank's US operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 10.1% ownership stake in Charles Schwab.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.